Home

Welcome to the HealthTech Investor Days (HTID) by France Biotech.

A European business event under the High Patronage of Mr Emmanuel MACRON President of the French Republic and the support of the French Ministry for the Economy and Finance, Mr Bruno Le Maire.

For the first time, the European Life Sciences community is organizing a international business event to connect leading worldwide investors, pharmaceutical companies and European C-level executives innovative companies in HealthTech.

France Biotech has the ambition to make the city of Paris a European place for business meetings for international investors (European, American and Asian) and innovative HealthTech companies.

« Europe is a land of innovation in health with many start-up and SME’s looking for financing to make their innovations avalaible to patients and to meet the medical challenges of tomorrow. The objective of the HTID is to become a reference place for exchanges between European HealthTech companies, international investors and pharmaceutical groups », said Maryvonne Hiance, chairman of France Biotech

Meet us on June 24th & 25th 2019

About the event

This HealthTech Investor Days, a European Business event, will take place in Paris on June 24th & 25th , under the High Patronage of Mr Emmanuel MACRON President of the French Republic and the support of the French Ministry for the Economy and Finance, Mr Bruno Le Maire. 

The two-day event will feature thematic panel discussion and one-on-one metings intented for European HealthTech companies, worldwide investors and pharmaceutical companies.

European targeted companies:
This event is organized for private and listed European companies willing to address leading investors and looking to raise funds.

The HTID is targeting :

  • European listed innovative companies in HealthTech (biotech, medtech, digital-health) with a market-cap starting from around €20 million
  • An on-going Phase II minimum for private biotech companies
  • CE or FDA approved product for medtech companies

If your project meets our requirements, please complete our dedicated application form  to submit an expression of interest.

This event takes place at the Peninsula Paris and includes:

  • Investors one-on-one meetings between innovative HealthTech companies and investors: French, European, American, Asian hedge funds, VC, banks for near and long-term investment;
  • Partnering one-on-one meetings with pharmaceuticals companies such as Servier, Sanofi , Ipsen, Guerbet, Pfizer, Takeda, Amgen …;
  • Conferences and thematic panel discussions on specific topics supervised by well-known international scientific Key Opinion Leaders;
  • Networking events with special guests on Monday and Tuesday evening.

More information: Contact us HERE

Program

BUSINESS PROGRAM

June 24th & 25th 2019 all day:
Where: The Peninsula Paris
When: All day long

MONDAY 24th

From 8am to 7pm: 1×1 meetings between international investors, European biotech, medtech, digital health and pharmaceutical companies (except on lunch break)

From 8am to 7pm: TV Studio for speakers & VIPs

12:30pm – 2pm: networking lunch

1pm to 1:45pm: Press conference with accredited journalists

2pm – 2:30pm: Grand Opening with Maryvonne Hiance, Chairman FRANCE BIOTECH and Bruno Le Maire French Minister of Economy and Finance (*)

2:30pm – 3:45pm: European attractiveness 
Moderated by Christian Pierret, Former French Minister of Industry
Speakers: 
Jean-Marc Bourez, Managing Director France – EIT HEALTH
Dr Ahmed Bouzidi, President – EBE
Thibault Roulon, Investment Director at Innobio – BPI France 
Joanna Dupont-Inglis, General Secretary – EUROPABIO
Ivana Magovčević-Liebisch, Executive VP & CBO – IPSEN

3:45pm – 4:15pm: Innovation in Healthcare in 2030
Moderated by Thomas Borel, Head of Scientific Affairs – LEEM
Speakers:
Frederic Collet, Chairman – LEEM / Chairman – NOVARTIS France
Jean-Christophe Tellier, Chairman of the Innovation Board – EFPIA and CEO UCB PHARMA

4:15pm – 4:30pm: Networking break

4:30pm – 5:15pmDiversity of investments: what are the key benefits and challenges?
Moderated by Paul Barrett – Facilitator
Speakers:
Lorenzo Bini Smaghi, Chairman – SOCIETE GENERALE
Marc Le Bozec, Fund Manager Private Equity – FINANCIERE ARBEVEL
Cédric Moreau, Partner – SOFINNOVA PARTNERS 
Sophie Pierrin Lepinard, Investment manager in Healthcare – BNP PARIBAS DEVELOPPEMENT

5:15pm – 6:30pm: Financing & investing in the Healthtech industry
Moderated by Eric Forest, Head of listing France – EURONEXT 
Speakers:
Alain Decombe, Paris Managing Partner – DECHERT LLP 
Olivier Garnier, Founder & Managing Partner – BRYAN, GARNIER & CO
Isabella Schidrich, Senior Managing Director – NASDAQ STOCK EXCHANGE
Lilian Stern, Principal – STERN IR 

6:30pm: – Day 1 cocktail reception at the Peninsula Paris

 

TUESDAY 25th

From 8am to 7pm: 1×1 meetings between international investors, European biotech, medtech, digital health and pharmaceutical companies (except on lunch break)

From 8am to 7pm: TV Studio for speakers & VIPs

8am – 9:30am: Hot topic in oncology: beyond autologous CAR-T and ANTI-PD1 / ANTI-PD1-L1 … what’s next? 
Moderated by:
Claude Bertrand, Executive Vice President Research and Development – SERVIER
Wolf Hervé Fridman, Professor of immunology – UNIVERSITY PARIS DESCARTES
Speakers:
Fabrice Denis, Oncologist – CENTRE JEAN BERNARD
Joël Doré, Research Director – INRA
Alexander Eggermont, General Director – GUSTAVE ROUSSY INSTITUTE
Damien Tremolet, CEO – IDDI

9:30am – 10am: Keynotes
Serge WeinbergChairman of the Board of Directors – SANOFI
Hervé Brailly, Chairman – INNATE PHARMA 

10am – 10:30am: Networking break 

10:30am – 12am: Synergies between business development and fund raising
Moderated by:
Eric Falcand, Vice President Global Head of Business Development & Licensing – SERVIER
Christian Policard, Senior Partner – BDC LIFESCIENCES
Speakers:
Nissim Darvish, Senior Managing Director – ORBIMED
Franck Grimaud, CEO – VALNEVA
Jongmoon Kim , CEO – TOOLGEN
Julie Puype, General Manager – TAKEDA France
Oded N Spindel, PhD, MBA, Vice President – H.C. Wainwright & Co, USA

12am – 1pm: European strengths in Artificial Intelligence in Healthcare
Moderated by Francois Nicolas, Chief Digital Officer – GUERBET
Speakers:
– Nozha Boujemaa, Chief Science & Innovation Officer – MEDIAN TECHNOLOGIES
– Stéphanie Combes, Health Data Hub Manager – attached to the Ministry of Health 
Philippe Chambon, Venture Partner – LBO Ventures 
Françoise Simon, Professor University of Columbia / University of Nantes 
– Wim Van Hecke, CEO – Icometrix                                                                              

1pm – 2:30pm: Networking lunch 

2:30 – 3pm: Keynote (*)

3pm – 3:45pm: Innovative start-up & pharmaceutical companies: a winning duo? 
Moderated by Paul Barrett – Facilitator 
Speakers:
– BOEHRINGER  INGELHEIM / OSE IMMUNOTHERAPEUTICS
– AMGEN / OWKIN
IPSEN / work in progress

 3:45pm – 4:15pm: Networking break 

4:15pm – 5:45pm: The American entrepreneurship model in Healthcare sciences: what are the best practices? 
Moderated by Pierre Courteille, CCO & VP BD – ABIVAX
Speakers:
Gil Beyen, Chairman & CEO – ERYTECH PHARMA SA
Jeffrey Hubbell, PhD, Eugene Bell Professor in Tissue Engineering – UNIVERSITY OF CHICAGO
Sophie Kornowski, Senior Partner – GURNET POINT CAPITAL LLC
Starr Marcello, MBA, Assistant Professor of Entrepreneurship – UNIVERSITY OF CHICAGO
Melody Swartz, PhD, William B. Ogden Professor of Molecular Engineering – UNIVERSITY OF CHICAGO

5:45pm – 6:15pm: The « Bridging Academia with Industry » model  
Moderated by Paul Barrett – Facilitator 
Speaker:
Gabriela Apiou, PhD, Director of Strategic Alliances – MASS GENERAL RESEARCH INSTITUTE and Assistant Professor of Dermatology – HARVARD MEDICAL SCHOOL 

6:15pm: Closing speech with: 
 – Maryvonne Hiance, Chairman FRANCE BIOTECH
 – Agnès Pannier-Runacher – Minister of State attached to the Minister of Economy and Finance (*)

6:45pm: Closing cocktail reception

(*) : To be defined
This program might be changed

Contacts

Sophie Villedieu – France Biotech
Business Manager & US Communications
+33 (0)6 64 27 32 25
sophie.villedieu@france-biotech.org

With the assistance of Nathalie Donne in the organization
Nathalie Donne – Shape N Link
Co-founder and partner 
+33 (0) 6 67 67 44 97
nathalie.donne@shapenlink.com

Media contacts:
EUROPE:
Caroline Carmagnol / Tatiana Vieira – Alize RP 
+ 33 (0)1 44 54 36 66 / + 33 (0)6 31 13 76 20
France-biotech@alizerp.com

NORTH AMERICA:
Marion Janic / Kate Barrette – RooneyPartners LLC
+1.212.223.4017 / +1.212.223.0561 
mjanic@rooneyco.com / kbarrette@rooneyco.com

This event has been supervised by Maryvonne Hiance, Chairman of France Biotech